DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Olfactory transduction	R-HSA-9751605	map04740	xylometazoline	5709	drug-path
Primary immunodeficiency	R-HSA-5601905	map05340	xylometazoline	5709	drug-path
Melanoma	Q9UHD0-PRO_0000015379	map05218	xylometazoline	5709	drug-path
Adipocytokine signaling pathway	R-HSA-168638	map04920	xylometazoline	5709	drug-path
Regulation of actin cytoskeleton	R-HSA-392751	map04810	xylometazoline	5709	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	xylometazoline	5709	drug-path
Gap junction	R-HSA-190861	map04540	xylometazoline	5709	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	xylometazoline	5709	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	xylometazoline	5709	drug-path
Pathways in cancer	R-HSA-9824443	map05200	xylometazoline	5709	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	xylometazoline	5709	drug-path
Prostate cancer	R-HSA-2990872	map05215	xylometazoline	5709	drug-path
Fc epsilon RI signaling pathway	R-HSA-2454202	map04664	xylometazoline	5709	drug-path
Alzheimer's disease	R-HSA-1643685	0	nimesulide	4495	drug-path
Olfactory transduction	R-HSA-9751605	map04740	nimesulide	4495	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	nimesulide	4495	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	nimesulide	4495	drug-path
Glioma	Q9NZM4	map05214	nimesulide	4495	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	nimesulide	4495	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	nimesulide	4495	drug-path